Laryngeal Airway Mask Market Size and Share
Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Base Year For Estimation | 2024 |
| Market Size (2025) | USD 521.60 Million |
| Market Size (2030) | USD 953.10 Million |
| Growth Rate (2025 - 2030) | 5.75% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Laryngeal Airway Mask Market Analysis by Mordor Intelligence
The laryngeal mask airways market size stands at USD 520.6 million in 2025 and is projected to climb to USD 953.1 million by 2030, delivering a 5.75% CAGR. Over the next five years, elective-surgery growth among aging populations, strong comparative-effectiveness data versus endotracheal tubes, and the post-pandemic shift to single-use supraglottic airway devices will sustain high replacement demand across operating rooms, ambulatory centers, and emergency services. Second-generation devices that integrate gastric drainage and achieve higher seal pressures expand clinical indications into laparoscopic, bariatric, and trauma cases, while office-based anesthesia and pre-hospital protocols pull the technology into new care settings. Competitive intensity remains moderate, yet innovation cycles are accelerating as suppliers defend brand loyalty through product upgrades, service contracts, and emerging sustainability claims.
Key Report Takeaways
By product type, disposable masks held 62.45% of laryngeal mask airways market share in 2024, while second-generation disposable variants are projected to rise at an 8.11% CAGR through 2030.
By age group, adults accounted for 60.50% share of the laryngeal mask airways market size in 2024, whereas pediatric & neonatal applications are advancing at an 8.47% CAGR to 2030.
By end user, hospitals led with 58.89% revenue share in 2024; ambulatory surgical centers are set to expand at an 8.84% CAGR over the same horizon.
By geography, North America commanded 37.23% share of the laryngeal mask airways market in 2024, while Asia-Pacific is forecast to post the fastest 9.23% CAGR through 2030.
Global Laryngeal Airway Mask Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising global surgical volumes among aging populations | +1.2% | Global, led by North America & Europe | Long term (≥ 4 years) |
| Clinical advantages over endotracheal intubation | +0.9% | Global, strongest in developed markets | Medium term (2-4 years) |
| Single-use adoption to curb cross-infection | +1.1% | Global, post-pandemic acceleration | Short term (≤ 2 years) |
| Second-generation innovations with gastric drainage | +0.8% | North America, Europe, expanding to APAC | Medium term (2-4 years) |
| Office-based anesthesia expansion | +0.7% | North America & Europe, emerging APAC hubs | Medium term (2-4 years) |
| Emergency medicine and military adoption | +0.5% | Global, conflict-zone deployment | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Rising Global Surgical Volumes Among Aging Populations
Elective and urgent procedures keep climbing as life expectancy rises, pushing hospitals to favor devices that shorten turnover and minimize airway trauma. A 2024 propensity-score matched analysis in atrial-fibrillation ablation reported smoother emergence and fewer airway complications when laryngeal masks replaced endotracheal tubes. Comorbidity-laden seniors benefit from gentler airway options, making supraglottic devices integral to orthopedics, oncology, and cardiac surgery programs. Payment models now reward shorter recovery times, so operating-room directors increasingly standardize on LMAs to boost throughput.
Clinical Advantages Over Endotracheal Intubation
Randomized studies in pediatric cohorts documented lower respiratory adverse-event rates with LMAs versus tubes. Adult data echo the findings, citing reduced hemodynamic stress during neurosurgery and faster anesthesia induction in ENT procedures. These benefits dovetail with enhanced-recovery protocols, prompting guideline updates from professional societies.
Rapid Transition Toward Single-Use Devices
Benchmark trials show disposable LMAs maintain intracuff pressure stability better than reusable models, especially during nitrous-oxide anesthesia. Infection-control officers cite elimination of reprocessing errors, while ambulatory centers value predictable supply costs and rapid room turnover.
Second-Generation LMAs With Gastric Drainage
Products such as Ambu AuraGain deliver seal pressures up to 40 cmH₂O and channel gastric contents away from the airway. Teleflex’s dual-seal LMA Supreme targets high-BMI patients in laparoscopic surgery. Higher seal pressures broaden indications into pneumoperitoneum procedures that once demanded intubation.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Aspiration risk in high-risk patients | -0.8% | Global, acute-care settings | Short term (≤ 2 years) |
| Alternative devices (video laryngoscopes, ET tubes) | -0.6% | Developed markets | Medium term (2-4 years) |
| Environmental pushback on single-use plastics | -0.5% | Europe, North America | Long term (≥ 4 years) |
| Reimbursement pressure in low-income systems | -0.4% | Emerging markets | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Risk of Aspiration in High-Risk Patients
Despite gastric-drainage channels, many trauma and obstetric protocols still default to tubes for full-stomach patients. Newly revised combat-care guidelines omit supraglottic devices from certain phases due to aspiration fear.
Environmental Sustainability Pushback on Disposable Plastics
EU packaging regulations effective 2026 mandate recyclability, while the U.K.’s National Health Service urges a shift to reusable consumables and. Device makers are experimenting with bioplastics and take-back programs to hold European contracts.
Segment Analysis
By Product Type: Disposable Dominance Amid Premium Migration
Disposable masks generated 62.45% of laryngeal mask airways market revenue in 2024. Their infection-control edge convinced infection-prevention committees to adopt “single-use only” policies across many hospitals. Second-generation disposable units featuring gastric drainage and higher seal pressures are advancing at an 8.11% CAGR, raising average selling prices and offsetting commodity-line ASP compression. Reusables linger in resource-constrained health systems but lose ground as sterilization labor and traceability costs rise toward disposable parity. Specialty masks engineered for bariatric and robotic procedures carve out profitable micro-segments that encourage continuous R&D.
OEMs now optimize sterile-pouch logistics and lean inventory to match just-in-time surgery schedules. Regulatory audits spotlight sterilization process validation, favoring branded vendors with ISO-compliant quality systems. Environmental pushback is real, yet early-stage bioplastic prototypes indicate a feasible middle path between infection control and circular-economy mandates.
By Age Group: Pediatric & Neonatal Surge Ahead
Adults accounted for 60.50% share of the laryngeal mask airways market size in 2024, tracking the broader surgical patient mix. Pediatric and neonatal use, however, posts the fastest 8.47% CAGR through 2030 as randomized trials confirm superior outcomes compared with intubation in airway surgery. The Union of European Neonatal and Perinatal Societies now recommends LMAs in resuscitation when intubation skills are scarce. Device makers therefore roll out micro-cuff models sized for infants under 2 kg.
Asia’s NICU build-outs––notably in regional Chinese trauma centers––boost neonatal demand, while U.S. pediatric dental surgeries add outpatient volume. The demographic mix shift raises design complexity and triggers stricter regulatory scrutiny, forming an IP moat around incumbents.
By End User: Ambulatory Centers Lead Growth
Hospitals delivered 58.89% of 2024 revenue thanks to high surgical volumes and early adoption of advanced technologies. Ambulatory surgical centers, however, show the sharpest 8.84% CAGR as payers steer procedures toward same-day discharge. LMAs align with ASC throughput metrics—swift insertion, minimal sore throat, and faster recovery—prompting administrators to bundle them into fixed-cost procedure packs. Specialty clinics in ENT and fertility embrace LMAs for hands-free ventilation, while pre-hospital providers extend total addressable demand by standardizing supraglottic airways in advanced life-support kits.
In military medicine, forward surgical teams stock compact LMA kits for prolonged field care, citing ease of use and rapid seal attainment. Collectively, this end-user diversification boosts device volumes beyond traditional OR confines.
Geography Analysis
North America captured 37.23% of global revenue in 2024 due to advanced OR infrastructure, anesthesiology training depth, and Medicare reimbursement stability. U.S. hospitals sign multi-year distributor contracts that bundle LMAs with regional block needles and monitoring disposables, locking in volume visibility. Canada mirrors these trends, while private hospitals in Mexico adopt second-generation masks to compete for cross-border medical tourism.
Asia-Pacific exhibits the fastest 9.23% CAGR to 2030, propelled by health-infrastructure spending and rapidly rising surgical capacity. Chinese provincial tenders bundle supraglottic devices with anesthesia circuits, and India’s public-private hospitals specify single-use masks to meet infection-control targets. Multinational brands defend share in tier-1 centers through published clinical evidence and local manufacturing tie-ups, while domestic challengers compete on price in tier-2 cities. Regulatory convergence with ISO 13485 eases foreign registrations yet demands on-site audits, raising entry costs for smaller exporters.
Europe delivers mid-single-digit growth but pioneers environmental regulation. The new electronic-instructions framework cuts paperwork costs for suppliers, yet 2026 packaging mandates heighten compliance spend. Middle East markets grow swiftly on hospital mega-projects in Saudi Arabia and the UAE, both reliant on high-acuity surgical caseloads. African demand remains concentrated in donor-funded trauma centers, while South American expansion is led by Brazil’s MDR-aligned regulatory reforms.
Together, these regional dynamics ensure that the laryngeal mask airways market continues to divide between high-income markets focused on premium innovations and emerging economies seeking accessible, cost-reliable solutions.
Competitive Landscape
Roughly half of global revenue is concentrated among the five largest suppliers, signaling moderate consolidation. Teleflex tops the table through its LMA family and strengthened hospital access after the EUR 760 million BIOTRONIK vascular-intervention acquisition. Ambu reported 19.5% organic growth in FY 2024/25, buoyed by AuraGain upgrades and the launch of SureSight Connect video laryngoscopy, which enlarges its cross-selling platform.
Intersurgical’s i-gel, Verathon, and Mercury Medical focus on niche designs or regional distribution agreements. Sustainability differentiation emerges as a fresh battleground: Ambu pilots bioplastic components, and Teleflex trials recyclable pouches in Dutch hospitals. Barriers to entry rest on ISO-compliant sterile manufacturing, extensive clinical-trial evidence, and global regulatory coverage, limiting new entrants to specialty or price-fighter roles.
Forward strategies revolve around AI-enabled cuff-pressure monitoring, extended-wear designs for prolonged surgery, and closed-loop inventory systems that marry LMAs with digital traceability. Suppliers pursuing these avenues aim to embed devices deeper into hospital value chains, thereby cementing renewal contracts in an increasingly data-driven procurement environment.
Laryngeal Airway Mask Industry Leaders
-
Teleflex Incorporated
-
Intersurgical Ltd
-
Medline Industries, Inc
-
Asid Bonz GmbH
-
Ambu A/S
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- July 2025: Teleflex agreed to buy BIOTRONIK’s vascular-intervention unit for EUR 760 million, closing the deal in July 2025
- May 2022: Medline acquired ASID BONZ, a medical device company that manufactures and provides laryngeal airway masks.
Global Laryngeal Airway Mask Market Report Scope
As per the scope of the report, a laryngeal mask airway (LMA), also known as the laryngeal mask, is a single-use or reusable supraglottic airway device that may be used as a temporary method to maintain an open airway. The Laryngeal Airway Mask Market is Segmented by Product Type (Reusable, Disposable), End-user (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across the major regions globally. The report offers the value (USD million) for the above segments.
| Disposable Laryngeal Masks |
| Reusable Laryngeal Masks |
| Specialty / Second-Generation Masks |
| Adult |
| Pediatric & Neonatal |
| Hospitals |
| Ambulatory Surgical Centres |
| Speciality Clinics |
| Pre-hospital Care Settings |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa |
| By Product Type (Value) | Disposable Laryngeal Masks | |
| Reusable Laryngeal Masks | ||
| Specialty / Second-Generation Masks | ||
| By Age Group (Value) | Adult | |
| Pediatric & Neonatal | ||
| By End User (Value) | Hospitals | |
| Ambulatory Surgical Centres | ||
| Speciality Clinics | ||
| Pre-hospital Care Settings | ||
| By Geography (Value) | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| South Korea | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
What CAGR is projected for global demand through 2030?
The laryngeal mask airways market is forecast to grow at 5.75% from 2025 to 2030.
Which clinical setting shows the fastest unit growth?
Ambulatory surgical centers expand usage at an 8.84% CAGR as payers steer procedures to outpatient venues.
Which product sub-category leads revenue and why?
Disposable LMAs hold 62.45% share thanks to infection-control priorities and lower reprocessing costs.
Where is regional momentum highest?
Asia-Pacific posts the quickest 9.23% CAGR, fueled by hospital build-outs and rising surgical volume.
How are environmental policies influencing procurement?
EU and U.K. regulations push hospitals to demand recyclable or reusable mask options, pressuring suppliers to adopt bioplastics and take-back schemes.
What is the biggest barrier to universal adoption?
Persistent aspiration-risk concerns in high-risk or full-stomach patients keep endotracheal intubation as the default in some emergency and obstetric scenarios.
Page last updated on:
